Document is current

Any future updates will be listed below

Semaglutide 7,2 mg settimanale in adulti con obesità (STEP UP): un trial randomizzato controllato di fase 3b

Crossref DOI link: https://doi.org/10.1007/s40619-025-01731-9

Published Online: 2025-11-03

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark